Other OTC - Delayed Quote USD

Eastwood Bio-Medical Canada Inc. (EWOOF)

0.6937 0.0000 (0.00%)
At close: November 7 at 11:56 AM EST
Currency in CAD All numbers in thousands
Download
Breakdown
TTM
10/31/2023
10/31/2022
10/31/2021
10/31/2020
Total Revenue
736.7510
867.9360
1,299.7630
981.0510
718.3360
Cost of Revenue
294.6920
319.5710
397.0190
522.6810
538.7640
Gross Profit
442.0570
548.3650
902.7440
458.3700
179.5720
Operating Expense
944.9270
1,053.5670
1,032.0890
1,054.2200
1,031.4120
Operating Income
-502.8700
-505.2020
-129.3450
-595.8500
-851.8400
Net Non Operating Interest Income Expense
-24.9490
-28.1640
-10.7050
-2.7880
-1.0050
Other Income Expense
-3.7840
-13.2320
-9.8290
-4.9550
0.4120
Pretax Income
-531.6030
-546.5980
-149.8790
-603.5930
-852.4330
Net Income Common Stockholders
-531.6030
-546.5980
-149.8790
-603.5930
-852.4330
Diluted NI Available to Com Stockholders
-531.6030
-546.5980
-149.8790
-603.5930
-852.4330
Basic EPS
-0.01
-0.01
-0.00
-0.01
-0.01
Diluted EPS
-0.01
-0.01
-0.00
-0.01
-0.01
Basic Average Shares
68,885.9690
68,885.9690
68,885.9690
68,885.9690
68,885.9690
Diluted Average Shares
68,885.9690
68,885.9690
68,885.9690
68,885.9690
68,885.9690
Total Expenses
1,239.6190
1,373.1380
1,429.1080
1,576.9010
1,570.1760
Net Income from Continuing & Discontinued Operation
-531.6030
-546.5980
-149.8790
-603.5930
-852.4330
Normalized Income
-527.8190
-533.3660
-139.4650
-598.6380
-852.4330
Interest Income
--
--
--
--
1.3690
Interest Expense
10.7050
28.1640
10.7050
2.7880
--
Net Interest Income
-24.9490
-28.1640
-10.7050
-2.7880
-1.0050
EBIT
-516.1020
-518.4340
-139.1740
-600.8050
-851.8400
EBITDA
-408.5780
-410.5820
-32.3230
-495.5040
-746.0960
Reconciled Cost of Revenue
294.6920
319.5710
397.0190
522.6810
538.7640
Reconciled Depreciation
107.5240
107.8520
106.8510
105.3010
105.7440
Net Income from Continuing Operation Net Minority Interest
-531.6030
-546.5980
-149.8790
-603.5930
-852.4330
Total Unusual Items Excluding Goodwill
-3.7840
-13.2320
-10.4140
-4.9550
--
Total Unusual Items
-3.7840
-13.2320
-10.4140
-4.9550
--
Normalized EBITDA
-404.7940
-397.3500
-21.9090
-490.5490
-746.0960
10/31/2020 - 8/2/2018

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade